Overexpression of the Brm subunit in human breast cancer cells led to increased exon inclusion in a handful of genes examined and siRNA knockdown of Brm abolished RNAPII accumulation on the same variant exons [7]. This evidence concerns the gene SMARCA2 and breast cancer.